A new app helps patients with muscular dystrophy control a robotic exoskeleton that assists with everyday tasks like drinking a glass of water or turning on a light switch.
Agilent Technologies said Wednesday it has entered an agreement to acquire privately held Genohm, a developer of unique cloud-based software solutions for laboratory management.
For the first time, scientists have revealed the essential genes for the most deadly human malaria parasite, Plasmodium falciparum. They have created new genomic techniques to analyse every gene in the parasite and determine which ones are indispensable.
Scientists have shown that boosting cells’ ability to process misfolded proteins could keep them from aggregating inside the cell, significantly delaying the onset of blindness in mice.
Researchers have created tools that would enable real-time activation of target genes in specific locations in the genome.
SOPHiA GENETICS, has announced that its technology for clinical genomics has reached a key milestone in helping better diagnose 200’000 patients. Already deployed in over 430 hospitals across 60 countries SOPHiA analyses today 1 patient every 5 minutes.
Biohacker, Aaron Traywick who publicly injected himself with his own developmental HSV treatment has passed away in Washington D.C.
There is concern that the White House is considering imposing further limits on research by Chinese citizens in the United States, saying that “scientific progress depends on openness, transparency, and the free flow of ideas”
Was the emergence of animals a small step in evolution, or did it represent a big leap in the DNA that carries the instructions for life?
Technologies for amplifying, sequencing and matching DNA have created new opportunities in genomic science. But there are ethical and social implications.
Denmark-based drugmaker Novo Nordisk has invested more in lobbying and doubled political donations since 2015.
U.S. regulators approved Novartis’ cell therapy Kymriah for the treatment of patients with a second type of blood cancer.
Now, Salk researchers have demonstrated in mice that haemophilia B can be treated for life with one single injection, containing disease-free liver cells that can produce their missing clotting factor.
The link between cancer mutations and DNA repair mechanisms has been well established. However, the specific origins of the mutation in these essential pathways have remained enigmatic. Now, researchers have used human and worm data to explore the mutational causes of cancer.
Harvard scientist, George Church is putting his efforts into using an alternative, older technology in a bid to recode an entire human genome in hundreds of thousands of locations in order to make it immune to viruses.